Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5): 363-385. doi: 10.3322/caac.21565 [17] Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018[J]...
The effective treatment of HCV relies on early diagnosis and antiviral medication. This is essential to minimize liver damage and prevent transmission. In more affluent countries like the U.S., the focus is on screening high-risk groups such as dialysis patients and injection drug users [1]. H...
For treatment monitoring, the diagnostics must be highly sensitive to support the sustained virological response (SVR) standard for successful treatment, which equates to the virus being undetectable in the bloodstream [7]. Currently, treatment monitoring is carried out using quantitative RNA testing, ...
Nivolumab is the first FDA-approved anti-PD-1 monoclonal antibody and has been approved for the treatment of several cancers, including esophageal squamous cell carcinoma, CRC and head and neck cancer [62,63,64]. In 2017, it was approved by the FDA as the second-line treatment for HCC pat...
The treatment options for HCC depend on several factors, including the cancer stage, the patient's overall health, and other individual factors8. Surgery is typically the preferred treatment for early-stage HCC9. However, elderly patients may be more vulnerable to the side effects of surgery. Li...
Treatment rec- ommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology. 2008;48:1070-1078.Tong MJ, Hsien C, Hsu L, et al.: Treatment recommendations for chronic hepatitis B: an evaluation of current ...
that can be exploited for the treatment of BTC patients. Beyond targeted therapies, active research avenues explore the development of novel therapeutics that target the crosstalk between cancer and stroma, the cellular pathways involved in the regulation of cell death, the chemoresistance phenotype and...
H Yesil,S Hepguler,U Dundar,... - 《Annals of the Rheumatic Diseases》 被引量: 0发表: 2017年 A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain Fentanyl has been incorporated into a transdermal therapeutic system (TTS) containing a rate-limiting...
current treatment strategies, and around 20–40% of patients with RA do not clinically benefit from these treatments. The unmet need for new treatment options for RA has prompted research in the development of novel agents acting through physiologically and pharmacologically relevant targets. Here we...
Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list. Hepatol Baltim Md. 2017;65(3):777–88. https://doi.org/10.1002/hep.28926. Article Google Scholar Carbone M, Mutimer D, Neuberger J. Hepatitis C virus and nonliver solid organ transplantation. ...